Healthcare Chromatography Instrument Market

Liquid chromatography systems is expected to account for 37.0% share of product type in 2026 and direct sales represent 41.0% of distribution channel. Pharmaceutical and biotechnology companies capture 39.0% of end user due to recurring validated testing and biologic characterization despite high equipment costs and difficult method transfers.